PTJ
TMO icon

Paul Tudor Jones’s Thermo Fisher Scientific TMO Stock Holding History

Paul Tudor Jones’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
32,600
+30,600
+1,530% +$14.7M 0.02% 578
2026
Q1 		$983K Sell
2,000
-4,600
-70% -$2.5M ﹤0.01% 2387
2025
Q4 		$3.82M Sell
6,600
-83,800
-93% -$47.4M 0.01% 1325
2025
Q3 		$43.8M Buy
90,400
+15,200
+20% +$7.08M 0.08% 201
2025
Q2 		$30.5M Buy
+75,200
New +$31.4M 0.07% 225
2025
Q1 		– Sell
-600
Closed -$312K – 3678
2024
Q4 		$312K Sell
600
-1,000
-63% -$550K ﹤0.01% 2555
2024
Q3 		$990K Buy
+1,600
New +$947K ﹤0.01% 1625
2024
Q2 		– Sell
-12,500
Closed -$7.27M – 2797
2024
Q1 		$7.27M Sell
12,500
-21,500
-63% -$12.1M 0.05% 470
2023
Q4 		$18M Buy
34,000
+25,800
+315% +$12.5M 0.15% 148
2023
Q3 		$4.15M Buy
8,200
+4,300
+110% +$2.29M 0.04% 575
2023
Q2 		$2.03M Buy
+3,900
New +$2.1M 0.02% 891
2023
Q1 		– Sell
-2,900
Closed -$1.59M – 2950
2022
Q4 		$1.59M Buy
+2,900
New +$1.54M 0.03% 775

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Paul Tudor Jones's TMO Position: Q2 2026 in Review

Paul Tudor Jones increased its Thermo Fisher Scientific (TMO) stake by 426% in Q2 2026, buying an estimated $27.7M and bringing the position to 71,244 shares worth $35.7M. The position accounts for 0.05% of the portfolio, ranked #281.

Paul Tudor Jones first reported a position in TMO in Q2 2013 and has held it in 35 quarters since. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Paul Tudor Jones held 71,244 shares of Thermo Fisher Scientific worth $35.7M as of Q2 2026.
  • Paul Tudor Jones bought 57,710 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.7M.
  • Thermo Fisher Scientific made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #281 holding.
  • Paul Tudor Jones first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 35 quarters since.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.